Evidence map›Paper›PMID 37175647›Full record

ArticleInternational journal of molecular sciences2023

The

Maria Makarova, Marina Nemtsova, Anastasiia Danishevich, Denis Chernevskiy, Maxim Belenikin, Anastasiia Krinitsina, Elena Baranova, Olesya Sagaydak, Maria Vorontsova, Igor Khatkov and 7 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biomedicines · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Maria MakarovaLLC Evogen, 115191 Moscow, Russia.ORCID 0000-0003-1581-9118
Marina NemtsovaLLC Evogen, 115191 Moscow, Russia.
Anastasiia DanishevichSBHI Moscow Clinical Scientific Center Named after Loginov MHD, 111123 Moscow, Russia.
Denis ChernevskiyLLC Evogen, 115191 Moscow, Russia.
Maxim BelenikinLLC Evogen, 115191 Moscow, Russia.
Anastasiia KrinitsinaLLC Evogen, 115191 Moscow, Russia.
Elena BaranovaLLC Evogen, 115191 Moscow, Russia.
Olesya SagaydakLLC Evogen, 115191 Moscow, Russia.
Maria VorontsovaThe National Medical Research Center for Endocrinology, 117292 Moscow, Russia.
Igor KhatkovSBHI Moscow Clinical Scientific Center Named after Loginov MHD, 111123 Moscow, Russia.
Lyudmila ZhukovaSBHI Moscow Clinical Scientific Center Named after Loginov MHD, 111123 Moscow, Russia.ORCID 0000-0003-4848-6938
Natalia BodunovaSBHI Moscow Clinical Scientific Center Named after Loginov MHD, 111123 Moscow, Russia.
Sergey NikolaevSBHI Moscow Clinical Scientific Center Named after Loginov MHD, 111123 Moscow, Russia.
Mariya ByakhovaCity Clinical Oncological Hospital No. 1, Moscow Department of Healthcare, 117152 Moscow, Russia.
Anna SemenovaCity Clinical Oncological Hospital No. 1, Moscow Department of Healthcare, 117152 Moscow, Russia.
Vsevolod GalkinCity Clinical Oncological Hospital No. 1, Moscow Department of Healthcare, 117152 Moscow, Russia.
Saida GadzhievaCity Clinical Oncological Hospital No. 1, Moscow Department of Healthcare, 117152 Moscow, Russia.
Moscow Clinical Scientific Center · RUFederal State Budgetary Institution Russian Scientific Center of Roentgenoradiology · RUMinistry of Health of the Russian Federation · RURussian Medical Academy of Continuous Professional Education · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

More than 275 million people in the world are carriers of a heterozygous mutation of the

Indexed as

Breast NeoplasmsCystic Fibrosis Transmembrane Conductance RegulatorFemaleGenetic Predisposition to DiseaseGerm CellsHumansMutationCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorCFTRcystic fibrosishereditary cancer predisposition syndromeRussian cohort of patientsthe frequency of heterozygous carriage

Identifiers

PMID37175647
PMCPMC10178054
OpenAlexW4367317613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.